The NRG-HN004 trial showed that durvalumab did not improve outcomes vs cetuximab in locoregionally advanced head and neck squamous cell carcinoma undergoing radiotherapy with contraindications to ...

A ruling by the Georgia Court of Appeals has clarified that a trial court judge is "not bound" to accept fees agreed to by ...

A ruling by the Georgia Court of Appeals has clarified that a trial court judge is "not bound" to accept fees agreed to by ...